V
MRUS

Veritable’s Merus MRUS Stock Holding History

Veritable’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,410
Closed -$204K – 934
2021
Q4 		$204K Buy
+6,410
New +$181K ﹤0.01% 881

Other funds holding MRUS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Veritable's MRUS Position: Q1 2022 in Review

Veritable sold out of Merus (MRUS) in Q1 2022, closing a stake of 6,410 shares — an estimated $204K sold.

Veritable first reported a position in MRUS in Q4 2021 and held it in 1 quarter. The position peaked at $204K in Q4 2021. 95 funds tracked by Wall St. Rank hold MRUS as of Q1 2022.

  • Veritable reported no remaining Merus position as of Q1 2022 after selling out during the quarter.
  • Veritable sold 6,410 Merus shares in Q1 2022, an estimated $204K.
  • Veritable first reported a position in Merus in Q4 2021 and held it in 1 quarter.
  • Veritable's Merus position peaked at $204K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Merus as of Q1 2022.

Based on Veritable's 13F filing for Q1 2022, filed 11 May 2022.